Medicine Compliance Aid Stability
A3 · Amber 3 No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Protect from light
Protect from moisture
Protect from moisture - contains a desiccant if packaged as a bottle. Max 7 days in MCA.
22 November 2022
Capsules 60mg, 120mg
R2 · Red 2 Drug is not suitable for CAs due to theoretical reasons that cannot be mitigated.
2 December 2022
Lactation Safety Information
No published evidence of safety
Negligible levels anticipated in milk due to the drug’s properties and minimal maternal absorption
The use of vitamin supplements should be considered if there is concern about maternal deficiency of fat soluble vitamins
7 August 2020